Financial Disclosure

Shanghai – – September 29, 2026 -- Hengrui Pharma has licensed its investigational obesity and diabetes drug HRS-1596 to Novo Nordisk in a deal worth up to 2.6 billion US dollars, including a 300 million dollar upfront payment.

Novo secures global rights excluding Greater China

Under the agreement, Novo obtains exclusive rights to develop, manufacture and commercialise HRS-1596 worldwide, excluding the Chinese mainland, Hong Kong SAR, Macao SAR and Taiwan Region. Hengrui Pharma retains eligibility for royalties on net sales of the drug within Novo's licensed territory, on top of the milestone-based payments tied to development, regulatory and commercial targets.

Shanghai – – September 29, 2026 -- Zoomlion Heavy Industry Science & Technology Co., Ltd. has signed a US$300 million portfolio credit insurance policy alongside an initial US$50 million non-recourse factoring agreement, creating a tiered financing structure for the company's overseas installment receivables. The deals were finalized at the Zoomlion 2026 Global Financial Partners Summit in Shanghai on September 11.

New framework converts overseas receivables into standardized, investment-grade assets

Developed over six months with international insurers and financial institutions, the arrangement lets overseas installment receivables covered by the credit insurance policy be factored with an overseas bank on a non-recourse basis. The structure replaces transaction-by-transaction handling of overseas receivables with a scalable, replicable financing model.

Copenhagen – September 29, 2026 -- NKT used its Investor Day 2026 in Karlskrona, Sweden, to unveil a formal capital allocation framework and confirm that commercial operation at its expanded Karlskrona facility will begin in Q2 2027, slightly ahead of the original schedule.

NKT ties cash generation to a four-priority capital allocation framework

The company said it will maintain a robust balance sheet, targeting net interest-bearing debt to operational EBITDA below 0x. Beyond balance-sheet discipline, NKT will direct capital toward organic growth and strategically aligned, value-accretive acquisitions, commit to a minimum annual dividend of 20% of adjusted net profit with an ambition for a stable payout per share, and return excess cash via share buybacks or extraordinary dividends when conditions allow.

St. Helier – September 29, 2026 -- Petrus Advisers, which holds roughly 3.8% of Iveco Group N.V. shares, has publicly rejected Tata Motors' all-cash voluntary tender offer of €14.10 per share, arguing the bid fails to reflect fair value for Iveco shareholders.

Petrus says the offer undervalues Iveco against industry peers

In a presentation released today, Petrus Legal Strategies (Jersey) Limited and Petrus Advisers Limited outlined three core objections to the transaction. The investment firm argues the €14.10 price sits below comparable valuations for peer companies in the commercial vehicle sector.

Seoul – – September 29, 2026 -- SEMIFIVE has signed a contract worth approximately KRW 70.3 billion ($52 million) with a U.S.-based AI fabless company to develop a next-generation AI inference accelerator, marking the South Korean custom ASIC provider's largest single contract to date.

Deal size dwarfs prior order volumes

The contract alone equals more than 40% of SEMIFIVE's total 2025 orders of KRW 168.4 billion and roughly 60% of the KRW 118.9 billion in new orders booked during the first half of 2026. It also marks the company's first "Spec Hand-off" engagement in North America.

Shanghai – September 29, 2026 -- IASO Biotechnology reported a 90% objective response rate and 90% minimal residual disease (MRD) negativity rate for its BCMA-targeted in vivo CAR-T therapy IASO206, generated via a single intravenous infusion without lymphodepleting chemotherapy, in first-in-human Phase 1 data presented as a late-breaking oral session (LBA-11) at the 2026 International Myeloma Society Annual Meeting.

Calgary, AB – September 29, 2026 -- Canadian Pacific Railway Company (CPRC), the wholly owned subsidiary of Canadian Pacific Kansas City Limited (TSX: CP) (NYSE: CP), is issuing C$1.8 billion in notes across four tranches, guaranteed by parent CPKC.

CPRC structures debt sale across four maturities from 2030 to 2056

The offering comprises C$500 million of 4.20% Notes due 2030, C$550 million of 4.60% Notes due 2033, C$300 million of 4.90% Notes due 2037 and C$450 million of 5.40% Notes due 2056. The staggered maturity profile spans 4 to 30 years, giving CPKC a blended long-term debt structure.

Net proceeds target refinancing of existing CPRC debt

CPKC stated the funds will be used primarily for refinancing outstanding indebtedness and for general corporate purposes. Until deployed, unused proceeds may be parked in short-term investment-grade securities, money market funds or bank deposits.

Oakland – – September 29, 2026 -- Blue Shield of California has pledged a $300,000 multi-year investment to Alameda County Community Food Bank (ACCFB), marking the first deployment under the nonprofit insurer's new statewide Food as Health initiative.

Blue Shield becomes the first and largest corporate sponsor of ACCFB's Food as Medicine program

The funding will expand a program that delivers medically supportive food and nutrition education to eligible Medi-Cal members managing chronic conditions. The investment strengthens infrastructure, data collection, and evaluation systems needed to scale the model beyond its current reach.

Los Angeles and Toronto – September 29, 2026 -- BRC Group Holdings, Inc. (NASDAQ: RILY) has agreed to acquire Sangoma Technologies Corporation (TSX: STC; NASDAQ: SANG) in a deal valuing the communications provider at an enterprise value of approximately $204 million, or C$289 million.

Combined communications revenue reaches $441 million on a trailing-twelve-month basis

BRC's existing communications businesses and Sangoma generated a combined $441 million in trailing-twelve-month revenue as of June 2026, with $241 million from BRC's units and $200 million from Sangoma. BRC's communications portfolio alone produced approximately $52 million in segment income over the same period.

Wood Dale, Ill. – September 29, 2026 -- AAR CORP. (NYSE: AIR) reported first-quarter fiscal 2027 sales of $918 million, a 24% jump from $739.6 million a year earlier, as the aviation aftermarket supplier simultaneously disclosed a definitive agreement to acquire a 65% controlling interest in MRO Holdings.

Sales climb 24% on parts distribution and repair growth

The quarter ended September 29, 2026, saw growth across all three core segments. Parts Supply sales rose 31%, driven by 23% organic growth in new parts distribution across commercial and government markets. The Repair, Engineering & Software segment grew 31% on airframe MRO, component MRO, and software activity, while Government Solutions increased 4% on Mobility Systems strength.